Cassianne Robinson-Cohen
Last active: 9/20/2017

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Circulating levels of soluble Fas (sCD95) are associated with risk for development of a nonresolving acute kidney injury subphenotype. Bhatraju PK, Robinson-Cohen C, Mikacenic C, Harju-Baker S, Dmyterko V, Slivinski NSJ, Liles WC, Himmelfarb J, Heckbert SR, Wurfel MM (2017) Crit Care 21(1): 217
    › Primary publication · 28814331 (PubMed) · PMC5559814 (PubMed Central)
  2. eGFR and Albuminuria in Relation to Risk of Incident Atrial Fibrillation: A Meta-Analysis of the Jackson Heart Study, the Multi-Ethnic Study of Atherosclerosis, and the Cardiovascular Health Study. Bansal N, Zelnick LR, Alonso A, Benjamin EJ, de Boer IH, Deo R, Katz R, Kestenbaum B, Mathew J, Robinson-Cohen C, Sarnak MJ, Shlipak MG, Sotoodehnia N, Young B, Heckbert SR (2017) Clin J Am Soc Nephrol 12(9): 1386-1398
    › Primary publication · 28798221 (PubMed) · PMC5586568 (PubMed Central)
  3. Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD. Batacchi Z, Robinson-Cohen C, Hoofnagle AN, Isakova T, Kestenbaum B, Martin KJ, Wolf MS, de Boer IH (2017) Clin J Am Soc Nephrol 12(9): 1498-1506
    › Primary publication · 28768705 (PubMed) · PMC5586563 (PubMed Central)
  4. Low-Frequency Synonymous Coding Variation in CYP2R1 Has Large Effects on Vitamin D Levels and Risk of Multiple Sclerosis. Manousaki D, Dudding T, Haworth S, Hsu YH, Liu CT, Medina-Gómez C, Voortman T, van der Velde N, Melhus H, Robinson-Cohen C, Cousminer DL, Nethander M, Vandenput L, Noordam R, Forgetta V, Greenwood CMT, Biggs ML, Psaty BM, Rotter JI, Zemel BS, Mitchell JA, Taylor B, Lorentzon M, Karlsson M, Jaddoe VVW, Tiemeier H, Campos-Obando N, Franco OH, Utterlinden AG, Broer L, van Schoor NM, Ham AC, Ikram MA, Karasik D, de Mutsert R, Rosendaal FR, den Heijer M, Wang TJ, Lind L, Orwoll ES, Mook-Kanamori DO, Michaëlsson K, Kestenbaum B, Ohlsson C, Mellström D, de Groot LCPGM, Grant SFA, Kiel DP, Zillikens MC, Rivadeneira F, Sawcer S, Timpson NJ, Richards JB (2017) Am J Hum Genet 101(2): 227-238
    › Primary publication · 28757204 (PubMed) · PMC5544392 (PubMed Central)
  5. Kidney function is associated with an altered protein composition of high-density lipoprotein. Rubinow KB, Henderson CM, Robinson-Cohen C, Himmelfarb J, de Boer IH, Vaisar T, Kestenbaum B, Hoofnagle AN (2017) Kidney Int
    › Primary publication · 28754556 (PubMed)
  6. Does Secretory Clearance Follow Glomerular Filtration Rate in Chronic Kidney Diseases? Reconsidering the Intact Nephron Hypothesis. Chapron A, Shen DD, Kestenbaum BR, Robinson-Cohen C, Himmelfarb J, Yeung CK (2017) Clin Transl Sci 10(5): 395-403
    › Primary publication · 28675584 (PubMed) · PMC5593164 (PubMed Central)
  7. Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic Hemodialysis: The CRIC Study (Chronic Renal Insufficiency Cohort). Bansal N, McCulloch CE, Lin F, Alper A, Anderson AH, Cuevas M, Go AS, Kallem R, Kusek JW, Lora CM, Lustigova E, Ojo A, Rahman M, Robinson-Cohen C, Townsend RR, Wright J, Xie D, Hsu CY, CRIC Study Investigators* (2017) Hypertension 70(2): 435-443
    › Primary publication · 28674037 (PubMed) · PMC5521215 (PubMed Central)
  8. Associations of Vitamin D-Binding Globulin and Bioavailable Vitamin D Concentrations With Coronary Heart Disease Events: The Multi-Ethnic Study of Atherosclerosis (MESA). Robinson-Cohen C, Zelnick LR, Hoofnagle AN, Lutsey PL, Burke G, Michos ED, Shea SJC, Tracy R, Siscovick DS, Psaty B, Kestenbaum B, de Boer IH (2017) J Clin Endocrinol Metab 102(8): 3075-3084
    › Primary publication · 28472285 (PubMed) · PMC5546864 (PubMed Central)
  9. A Two Biomarker Model Predicts Mortality in the Critically Ill with Sepsis. Mikacenic C, Price BL, Harju-Baker S, O'Mahony DS, Robinson-Cohen C, Radella F, Hahn WO, Katz R, Christiani DC, Himmelfarb J, Liles WC, Wurfel MM (2017) Am J Respir Crit Care Med
    › Primary publication · 28418697 (PubMed)
  10. NFAT5 and SLC4A10 Loci Associate with Plasma Osmolality. Böger CA, Gorski M, McMahon GM, Xu H, Chang YC, van der Most PJ, Navis G, Nolte IM, de Borst MH, Zhang W, Lehne B, Loh M, Tan ST, Boerwinkle E, Grams ME, Sekula P, Li M, Wilmot B, Moon JG, Scheet P, Cucca F, Xiao X, Lyytikäinen LP, Delgado G, Grammer TB, Kleber ME, Sedaghat S, Rivadeneira F, Corre T, Kutalik Z, Bergmann S, Nielson CM, Srikanth P, Teumer A, Müller-Nurasyid M, Brockhaus AC, Pfeufer A, Rathmann W, Peters A, Matsumoto M, de Andrade M, Atkinson EJ, Robinson-Cohen C, de Boer IH, Hwang SJ, Heid IM, Gögele M, Concas MP, Tanaka T, Bandinelli S, Nalls MA, Singleton A, Tajuddin SM, Adeyemo A, Zhou J, Doumatey A, McWeeney S, Murabito J, Franceschini N, Flessner M, Shlipak M, Wilson JG, Chen G, Rotimi CN, Zonderman AB, Evans MK, Ferrucci L, Devuyst O, Pirastu M, Shuldiner A, Hicks AA, Pramstaller PP, Kestenbaum B, Kardia SLR, Turner ST, Study LC, Briske TE, Gieger C, Strauch K, Meisinger C, Meitinger T, Völker U, Nauck M, Völzke H, Vollenweider P, Bochud M, Waeber G, Kähönen M, Lehtimäki T, März W, Dehghan A, Franco OH, Uitterlinden AG, Hofman A, Taylor HA, Chambers JC, Kooner JS, Fox CS, Hitzemann R, Orwoll ES, Pattaro C, Schlessinger D, Köttgen A, Snieder H, Parsa A, Cohen DM (2017) J Am Soc Nephrol 28(8): 2311-2321
    › Primary publication · 28360221 (PubMed) · PMC5533231 (PubMed Central)
  11. Association of Vitamin D Metabolites With Arterial Function in the Hemodialysis Fistula Maturation Study. van Ballegooijen AJ, Zelnick L, Hoofnagle AN, Hamburg NM, Robinson-Cohen C, Roy-Chaudhury P, Cheung AK, Shiu YT, de Boer IH, Himmelfarb J, Beck G, Imrey PB, Kusek JW, Kestenbaum B, Hemodialysis Fistula Maturation (HFM) Study Group (2017) Am J Kidney Dis 69(6): 805-814
    › Primary publication · 28359657 (PubMed) · PMC5441944 (PubMed Central)
  12. Fibroblast Growth Factor 23, Mineral Metabolism, and Adiposity in Normal Kidney Function. Zaheer S, de Boer IH, Allison M, Brown JM, Psaty BM, Robinson-Cohen C, Michos ED, Ix JH, Kestenbaum B, Siscovick D, Vaidya A (2017) J Clin Endocrinol Metab 102(4): 1387-1395
    › Primary publication · 28323987 (PubMed) · PMC5460732 (PubMed Central)
  13. Growth Differentiation Factor-15 and Risk of CKD Progression. Nair V, Robinson-Cohen C, Smith MR, Bellovich KA, Bhat ZY, Bobadilla M, Brosius F, de Boer IH, Essioux L, Formentini I, Gadegbeku CA, Gipson D, Hawkins J, Himmelfarb J, Kestenbaum B, Kretzler M, Magnone MC, Perumal K, Steigerwalt S, Ju W, Bansal N (2017) J Am Soc Nephrol 28(7): 2233-2240
    › Primary publication · 28159780 (PubMed) · PMC5491285 (PubMed Central)
  14. Absolute Rates of Heart Failure, Coronary Heart Disease, and Stroke in Chronic Kidney Disease: An Analysis of 3 Community-Based Cohort Studies. Bansal N, Katz R, Robinson-Cohen C, Odden MC, Dalrymple L, Shlipak MG, Sarnak MJ, Siscovick DS, Zelnick L, Psaty BM, Kestenbaum B, Correa A, Afkarian M, Young B, de Boer IH (2017) JAMA Cardiol 2(3): 314-318
    › Primary publication · 28002548 (PubMed)
  15. Genetic Variants Associated with Circulating Parathyroid Hormone. Robinson-Cohen C, Lutsey PL, Kleber ME, Nielson CM, Mitchell BD, Bis JC, Eny KM, Portas L, Eriksson J, Lorentzon M, Koller DL, Milaneschi Y, Teumer A, Pilz S, Nethander M, Selvin E, Tang W, Weng LC, Wong HS, Lai D, Peacock M, Hannemann A, Völker U, Homuth G, Nauk M, Murgia F, Pattee JW, Orwoll E, Zmuda JM, Riancho JA, Wolf M, Williams F, Penninx B, Econs MJ, Ryan KA, Ohlsson C, Paterson AD, Psaty BM, Siscovick DS, Rotter JI, Pirastu M, Streeten E, März W, Fox C, Coresh J, Wallaschofski H, Pankow JS, de Boer IH, Kestenbaum B (2017) J Am Soc Nephrol 28(5): 1553-1565
    › Primary publication · 27927781 (PubMed) · PMC5407713 (PubMed Central)
  16. Effect of Coenzyme Q10 on Biomarkers of Oxidative Stress and Cardiac Function in Hemodialysis Patients: The CoQ10 Biomarker Trial. Rivara MB, Yeung CK, Robinson-Cohen C, Phillips BR, Ruzinski J, Rock D, Linke L, Shen DD, Ikizler TA, Himmelfarb J (2017) Am J Kidney Dis 69(3): 389-399
    › Primary publication · 27927588 (PubMed)
  17. Association of Muscle Endurance, Fatigability, and Strength With Functional Limitation and Mortality in the Health Aging and Body Composition Study. Roshanravan B, Patel KV, Fried LF, Robinson-Cohen C, de Boer IH, Harris T, Murphy RA, Satterfield S, Goodpaster BH, Shlipak M, Newman AB, Kestenbaum B, Health ABC study (2017) J Gerontol A Biol Sci Med Sci 72(2): 284-291
    › Primary publication · 27907890 (PubMed) · PMC5233917 (PubMed Central)
  18. Physical activity and metabolic health in chronic kidney disease: a cross-sectional study. Bowlby W, Zelnick LR, Henry C, Himmelfarb J, Kahn SE, Kestenbaum B, Robinson-Cohen C, Utzschneider KM, de Boer IH (2016) BMC Nephrol 17(1): 187
    › Primary publication · 27876008 (PubMed) · PMC5120456 (PubMed Central)
  19. Acute kidney injury subphenotypes based on creatinine trajectory identifies patients at increased risk of death. Bhatraju PK, Mukherjee P, Robinson-Cohen C, O'Keefe GE, Frank AJ, Christie JD, Meyer NJ, Liu KD, Matthay MA, Calfee CS, Christiani DC, Himmelfarb J, Wurfel MM (2016) Crit Care 20(1): 372
    › Primary publication · 27852290 (PubMed) · PMC5112626 (PubMed Central)
  20. Different components of blood pressure are associated with increased risk of atherosclerotic cardiovascular disease versus heart failure in advanced chronic kidney disease. Bansal N, McCulloch CE, Lin F, Robinson-Cohen C, Rahman M, Kusek JW, Anderson AH, Xie D, Townsend RR, Lora CM, Wright J, Go AS, Ojo A, Alper A, Lustigova E, Cuevas M, Kallem R, Hsu CY, CRIC Study Investigators (2016) Kidney Int 90(6): 1348-1356
    › Primary publication · 27717485 (PubMed) · PMC5123948 (PubMed Central)
  21. Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients. Robinson-Cohen C, Newitt R, Shen DD, Rettie AE, Kestenbaum BR, Himmelfarb J, Yeung CK (2016) PLoS One 11(8): e0161074
    › Primary publication · 27513517 (PubMed) · PMC4981377 (PubMed Central)
  22. Association of markers of endothelial dysregulation Ang1 and Ang2 with acute kidney injury in critically ill patients. Robinson-Cohen C, Katz R, Price BL, Harju-Baker S, Mikacenic C, Himmelfarb J, Liles WC, Wurfel MM (2016) Crit Care 20(1): 207
    › Primary publication · 27372077 (PubMed) · PMC4930837 (PubMed Central)
  23. Chronic Kidney Disease Alters Vitamin A Homeostasis via Effects on Hepatic RBP4 Protein Expression and Metabolic Enzymes. Jing J, Isoherranen N, Robinson-Cohen C, Petrie I, Kestenbaum BR, Yeung CK (2016) Clin Transl Sci 9(4): 207-15
    › Primary publication · 27277845 (PubMed) · PMC5351338 (PubMed Central)
  24. Detection of Drug-Induced Acute Kidney Injury in Humans Using Urinary KIM-1, miR-21, -200c, and -423. Pavkovic M, Robinson-Cohen C, Chua AS, Nicoara O, Cárdenas-González M, Bijol V, Ramachandran K, Hampson L, Pirmohamed M, Antoine DJ, Frendl G, Himmelfarb J, Waikar SS, Vaidya VS (2016) Toxicol Sci 152(1): 205-13
    › Primary publication · 27122240 (PubMed) · PMC5009468 (PubMed Central)
  25. Risk Factors for Rapid Kidney Function Decline Among African Americans: The Jackson Heart Study (JHS). Young BA, Katz R, Boulware LE, Kestenbaum B, de Boer IH, Wang W, Fülöp T, Bansal N, Robinson-Cohen C, Griswold M, Powe NR, Himmelfarb J, Correa A (2016) Am J Kidney Dis 68(2): 229-239
    › Primary publication · 27066930 (PubMed) · PMC5445065 (PubMed Central)
  26. Galectin-3 and Soluble ST2 and Kidney Function Decline in Older Adults: The Cardiovascular Health Study (CHS). Bansal N, Katz R, Seliger S, DeFilippi C, Sarnak MJ, Delaney JA, Christenson R, de Boer IH, Kestenbaum B, Robinson-Cohen C, Ix JH, Shlipak MG (2016) Am J Kidney Dis 67(6): 994-6
    › Primary publication · 26830253 (PubMed)
  27. Parathyroid Hormone and the Use of Diuretics and Calcium-Channel Blockers: The Multi-Ethnic Study of Atherosclerosis. Zaheer S, de Boer I, Allison M, Brown JM, Psaty BM, Robinson-Cohen C, Ix JH, Kestenbaum B, Siscovick D, Vaidya A (2016) J Bone Miner Res 31(6): 1137-45
    › Primary publication · 26748479 (PubMed) · PMC5424889 (PubMed Central)
  28. Vitamin D metabolites and bone mineral density: The multi-ethnic study of atherosclerosis. van Ballegooijen AJ, Robinson-Cohen C, Katz R, Criqui M, Budoff M, Li D, Siscovick D, Hoofnagle A, Shea SJ, Burke G, de Boer IH, Kestenbaum B (2015) Bone : 186-93
    › Primary publication · 25976951 (PubMed) · PMC4466133 (PubMed Central)
  29. Genetic and environmental factors are associated with serum 25-hydroxyvitamin D concentrations in older African Americans. Hansen JG, Tang W, Hootman KC, Brannon PM, Houston DK, Kritchevsky SB, Harris TB, Garcia M, Lohman K, Liu Y, de Boer IH, Kestenbaum BR, Robinson-Cohen C, Siscovick DS, Cassano PA (2015) J Nutr 145(4): 799-805
    › Primary publication · 25716552 (PubMed) · PMC4381765 (PubMed Central)
  30. Creatinine clearance, walking speed, and muscle atrophy: a cohort study. Roshanravan B, Patel KV, Robinson-Cohen C, de Boer IH, O'Hare AM, Ferrucci L, Himmelfarb J, Kestenbaum B (2015) Am J Kidney Dis 65(5): 737-47
    › Primary publication · 25542415 (PubMed) · PMC4414665 (PubMed Central)
  31. Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis. Bansal N, Zelnick L, Robinson-Cohen C, Hoofnagle AN, Ix JH, Lima JA, Shoben AB, Peralta CA, Siscovick DS, Kestenbaum B, de Boer IH (2014) J Am Heart Assoc 3(6): e001278
    › Primary publication · 25468653 (PubMed) · PMC4338718 (PubMed Central)
  32. Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis. Brown J, de Boer IH, Robinson-Cohen C, Siscovick DS, Kestenbaum B, Allison M, Vaidya A (2015) J Clin Endocrinol Metab 100(2): 490-9
    › Primary publication · 25412416 (PubMed) · PMC4318894 (PubMed Central)
  33. Changes in symptom burden and physical performance with initiation of dialysis in patients with chronic kidney disease. Rivara MB, Robinson-Cohen C, Kestenbaum B, Roshanravan B, Chen CH, Himmelfarb J, Mehrotra R (2015) Hemodial Int 19(1): 147-50
    › Primary publication · 25404416 (PubMed) · PMC4420177 (PubMed Central)
  34. Self-rated health and adverse events in CKD. Robinson-Cohen C, Hall YN, Katz R, Rivara MB, de Boer IH, Kestenbaum BR, Himmelfarb J (2014) Clin J Am Soc Nephrol 9(12): 2044-51
    › Primary publication · 25301857 (PubMed) · PMC4255401 (PubMed Central)
  35. Estimation of 24-hour urine phosphate excretion from spot urine collection: development of a predictive equation. Robinson-Cohen C, Ix JH, Smits G, Persky M, Chertow GM, Block GA, Kestenbaum BR (2014) J Ren Nutr 24(3): 194-9
    › Primary publication · 24759300 (PubMed)
  36. Estimated GFR and circulating 24,25-dihydroxyvitamin D3 concentration: a participant-level analysis of 5 cohort studies and clinical trials. de Boer IH, Sachs MC, Chonchol M, Himmelfarb J, Hoofnagle AN, Ix JH, Kremsdorf RA, Lin YS, Mehrotra R, Robinson-Cohen C, Siscovick DS, Steffes MW, Thummel KE, Tracy RP, Wang Z, Kestenbaum B (2014) Am J Kidney Dis 64(2): 187-97
    › Primary publication · 24703961 (PubMed) · PMC4111986 (PubMed Central)
  37. Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis. Kestenbaum B, Sachs MC, Hoofnagle AN, Siscovick DS, Ix JH, Robinson-Cohen C, Lima JA, Polak JF, Blondon M, Ruzinski J, Rock D, de Boer IH (2014) Circ Heart Fail 7(3): 409-17
    › Primary publication · 24668259 (PubMed) · PMC4031265 (PubMed Central)
  38. An estimation of the prevalence and progression of chronic kidney disease in a rural diabetic cambodian population. Thomas B, van Pelt M, Mehrotra R, Robinson-Cohen C, LoGerfo J (2014) PLoS One 9(1): e86123
    › Primary publication · 24465909 (PubMed) · PMC3899115 (PubMed Central)
  39. Physical activity and change in estimated GFR among persons with CKD. Robinson-Cohen C, Littman AJ, Duncan GE, Weiss NS, Sachs MC, Ruzinski J, Kundzins J, Rock D, de Boer IH, Ikizler TA, Himmelfarb J, Kestenbaum BR (2014) J Am Soc Nephrol 25(2): 399-406
    › Primary publication · 24335971 (PubMed) · PMC3904564 (PubMed Central)
  40. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. Robinson-Cohen C, Hoofnagle AN, Ix JH, Sachs MC, Tracy RP, Siscovick DS, Kestenbaum BR, de Boer IH (2013) JAMA 310(2): 179-88
    › Primary publication · 23839752 (PubMed) · PMC4150653 (PubMed Central)
  41. Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis. Sachs MC, Shoben A, Levin GP, Robinson-Cohen C, Hoofnagle AN, Swords-Jenny N, Ix JH, Budoff M, Lutsey PL, Siscovick DS, Kestenbaum B, de Boer IH (2013) Am J Clin Nutr 97(6): 1243-51
    › Primary publication · 23615830 (PubMed) · PMC3652923 (PubMed Central)
  42. Association between physical performance and all-cause mortality in CKD. Roshanravan B, Robinson-Cohen C, Patel KV, Ayers E, Littman AJ, de Boer IH, Ikizler TA, Himmelfarb J, Katzel LI, Kestenbaum B, Seliger S (2013) J Am Soc Nephrol 24(5): 822-30
    › Primary publication · 23599380 (PubMed) · PMC3636794 (PubMed Central)
  43. Geographic variation in black-white differences in end-of-life care for patients with ESRD. Thomas BA, Rodriguez RA, Boyko EJ, Robinson-Cohen C, Fitzpatrick AL, O'Hare AM (2013) Clin J Am Soc Nephrol 8(7): 1171-8
    › Primary publication · 23580783 (PubMed) · PMC3700690 (PubMed Central)
  44. Dietary phosphorus is associated with greater left ventricular mass. Yamamoto KT, Robinson-Cohen C, de Oliveira MC, Kostina A, Nettleton JA, Ix JH, Nguyen H, Eng J, Lima JA, Siscovick DS, Weiss NS, Kestenbaum B (2013) Kidney Int 83(4): 707-14
    › Primary publication · 23283134 (PubMed) · PMC3612378 (PubMed Central)
  45. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagström E, Michaëlsson K, Melhus H, Wang T, Wolf M, Psaty BM, Siscovick D, Kestenbaum B (2012) JAMA 308(18): 1898-905
    › Primary publication · 23150009 (PubMed) · PMC3645444 (PubMed Central)
  46. A prospective study of frailty in nephrology-referred patients with CKD. Roshanravan B, Khatri M, Robinson-Cohen C, Levin G, Patel KV, de Boer IH, Seliger S, Ruzinski J, Himmelfarb J, Kestenbaum B (2012) Am J Kidney Dis 60(6): 912-21
    › Primary publication · 22770927 (PubMed) · PMC3491110 (PubMed Central)
  47. Assessment of physical activity in chronic kidney disease. Robinson-Cohen C, Littman AJ, Duncan GE, Roshanravan B, Ikizler TA, Himmelfarb J, Kestenbaum BR (2013) J Ren Nutr 23(2): 123-31
    › Primary publication · 22739659 (PubMed) · PMC3496802 (PubMed Central)
  48. The serum 24,25-dihydroxyvitamin D concentration, a marker of vitamin D catabolism, is reduced in chronic kidney disease. Bosworth CR, Levin G, Robinson-Cohen C, Hoofnagle AN, Ruzinski J, Young B, Schwartz SM, Himmelfarb J, Kestenbaum B, de Boer IH (2012) Kidney Int 82(6): 693-700
    › Primary publication · 22648296 (PubMed) · PMC3434313 (PubMed Central)
  49. Serum 25-hydroxyvitamin D concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. de Boer IH, Levin G, Robinson-Cohen C, Biggs ML, Hoofnagle AN, Siscovick DS, Kestenbaum B (2012) Ann Intern Med 156(9): 627-34
    › Primary publication · 22547472 (PubMed) · PMC3632351 (PubMed Central)
  50. Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Pham H, Robinson-Cohen C, Biggs ML, Ix JH, Mukamal KJ, Fried LF, Kestenbaum B, Siscovick DS, de Boer IH (2012) Clin J Am Soc Nephrol 7(4): 588-94
    › Primary publication · 22383749 (PubMed) · PMC3315343 (PubMed Central)
  51. Mineral metabolism markers and the long-term risk of hip fracture: the cardiovascular health study. Robinson-Cohen C, Katz R, Hoofnagle AN, Cauley JA, Furberg CD, Robbins JA, Chen Z, Siscovick DS, de Boer IH, Kestenbaum B (2011) J Clin Endocrinol Metab 96(7): 2186-93
    › Primary publication · 21508146 (PubMed) · PMC3135189 (PubMed Central)
  52. An assessment of surgical thromboprophylaxis in a tertiary care center. Robinson-Cohen C, Pilon D, Dubois MF, Tagalakis V (2011) Clin Appl Thromb Hemost 17(6): E39-45
    › Primary publication · 20829273 (PubMed)
  53. Physical activity and rapid decline in kidney function among older adults. Robinson-Cohen C, Katz R, Mozaffarian D, Dalrymple LS, de Boer I, Sarnak M, Shlipak M, Siscovick D, Kestenbaum B (2009) Arch Intern Med 169(22): 2116-23
    › Primary publication · 20008696 (PubMed) · PMC2878734 (PubMed Central)
  54. The effect of anticoagulants on cancer risk and survival: systematic review. Tagalakis V, Blostein M, Robinson-Cohen C, Kahn SR (2007) Cancer Treat Rev 33(4): 358-68
    › Primary publication · 17408861 (PubMed)